ArticleDrug safety2022

Use of Identical INN "Imiglucerase" for Different Drug Products: Impact Analysis of Adverse Events in a Proprietary Global Safety Database.

So-Fai Tsang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.